COL1A1 and intervertebral disk degenerative disorder: miR-625-5p is upregulated in IDD and lipopolysaccharide (LPS)-treated human NP cells and human annulus fibrosus cells (hAFCs), and it targets collagen type I alpha 1 (COL1A1) (Shen et al. 2019).